Pleszewski B, FitzGerald J M
Department of Medicine, BC Centre for Disease Control Society, Ministry of Health, British Columbia, Canada.
Int J Tuberc Lung Dis. 1998 Nov;2(11):898-903.
To compare the clinical features and prevalence of active TB in British Columbia (BC) health-care workers (HCWs) with those of the general population, between 1991 and 1996.
Comparison of 25 HCWs and 50 controls randomly selected from the Centres for Disease Control registry, with respect to demographics, prevention, diagnosis and management.
HCWs had fewer related risk factors, but more had initiated prior chemoprophylaxis (16% vs. 0%, P < 0.01) and knew their bacille Calmette-Guerin (BCG) (68% vs. 24%, P < 0.001) and purified protein derivative (PPD) status (60% vs 32%, P < 0.05). There were no differences in symptom duration (3.3+/-3.6 vs. 3.0+/-3.4 months), mycobacteriology and diagnostic features, treatment duration (264.9+/-69.9 vs. 239.0+/-78.7 days) and completion rates (84% for both). All HCWs used self-administered treatment (100% vs. 70%, P < 0.01), and fewer were hospitalized (8% vs. 28%, P < 0.05). Disease rates in nurses (3.6+/-4.4 per 100 000) were lower than the general population rates (9.0+/-0.8), but did not differ among physiotherapists (8.96+/-21.95), general practitioners (7.60+/-11.78) and medical residents (30.75+/-75.32);
Clinical features were similar in HCWs, but management strategies differed. BC HCWs are not at increased risk of tuberculosis, but the small sample size limited the power of our study to detect such an increase.
比较1991年至1996年间,不列颠哥伦比亚省(BC)医护人员(HCWs)与普通人群中活动性肺结核的临床特征及患病率。
从疾病控制中心登记处随机选取25名医护人员和50名对照,比较其人口统计学、预防、诊断和管理情况。
医护人员相关风险因素较少,但更多人曾接受过化学预防(16%对0%,P<0.01),且了解自己的卡介苗(BCG)接种情况(68%对24%,P<0.001)和纯化蛋白衍生物(PPD)状态(60%对32%,P<0.05)。症状持续时间(3.3±3.6对3.0±3.4个月)、分枝杆菌学及诊断特征、治疗持续时间(264.9±69.9对239.0±78.7天)和完成率(均为84%)无差异。所有医护人员均采用自我给药治疗(100%对70%,P<0.01),住院人数较少(8%对28%,P<0.05)。护士的发病率(每10万人中3.6±4.4例)低于普通人群发病率(9.0±0.8),但物理治疗师(8.96±21.95)、全科医生(7.60±11.78)和住院医师(30.75±75.32)之间无差异;
医护人员的临床特征相似,但管理策略不同。BC省医护人员患结核病的风险未增加,但样本量较小限制了我们研究检测此类增加的能力。